Altered Brain Function During Memory Test Related to Increased Schizophrenia Risk

Functional impairment captured in two brain regions during a simple memory task may serve as a biomarker for schizophrenia.

Functional impairment captured in two brain regions during a simple memory task may serve as a biomarker for schizophrenia, according to a study published online January 1, 2014, in JAMA Psychiatry.

For their study, Roberta Rasetti, MD, PhD, and researchers at the National Institutes of Health (NIH) in Maryland observed 62 schizophrenia patients, 65 healthy siblings, and 181 control subjects. From there, “functional magnetic resonance imaging (MRI) was used with a simple visual declarative memory paradigm to test for differences in neural activation” across the 3 participant groups. During this test, the investigators analyzed “differences in hippocampus and parahippocampus activation and coupling across groups and correlations with accuracy.”

According to the researchers, the intention of the study was to “define whether the impairment in declarative memory and in the underlying related network is a trait or a state feature of schizophrenia.” Though the study mainly focused on genetics, the investigators explained that “it is preferable to study siblings rather than parents because age is a state factor that affects memory and brain physiology.”

The authors found that “both patients with schizophrenia and their healthy siblings showed reduced parahippocampal activation and hippocampal-parietal coupling during the encoding of novel stimuli when compared with normal control participants.” In addition, “there was a significant positive correlation between parahippocampal activation during encoding and the visual-memory score,” the researchers noted.

The results suggests that “hippocampal-parahippocampal dysfunction in schizophrenia is a familial, likely heritable, trait,” the authors wrote. ”We found that activation of the parahippocampus and hippocampal coupling with inferior parietal lobule (IPL) during the incidental encoding phase of the simple declarative memory task are impaired both in patients with schizophrenia and their healthy siblings.”

In light of those results, the investigators said neuroimaging to measure hippocampal-parahippocampal function “could prove useful in identifying neural system mechanisms for genetic susceptibility and as a potential biomarker for intervention” in schizophrenia.

Related Videos
Manpreet Singh, MD: The Different Subtypes of ADHD and Mood Disorders
Manpreet K. Singh, MD: The Challenge of Treating ADHD With Comorbidities
Jennifer Crosbie, PhD: A Video Game Platform for Improving Executive Function
Sanjai Rao, MD: Long-Acting Injectables for Schizophrenia
Anita Clayton, MD: Women's Issues in Psychiatry
Michael Thase, MD: Risk Factors for Chronically Depressed Patients
John J. Miller, MD: Guidance on Cannabis Use in Psychiatry
Christopher Schneck, MD: Early Interventions for Bipolar Disorder
Joseph Goldberg, MD: Treating Mixed Feature Depression
Related Content
© 2023 MJH Life Sciences

All rights reserved.